08 November 2024
08 November 2024
Lord Vallance stated the government sees investment, innovation, and public-private partnership as crucial to UK healthcare.
Vidac will use the new funds to initiate a Phase IIb trial of its lead candidate VDA-1102 in patients with actinic keratosis.
The ongoing Phase I trial of MB-108 at the University of Alabama at Birmingham is enrolling patients.
The company reported that it does not have sufficient cash reserves to operate for the next 12 months and can only fund operations into Q1 2025.
Under the agreement, Arctic Vision will receive up to $85m in upfront and milestone payments.
IL-18 plays a key role in regulating innate immune responses, affecting natural killer cells, monocytes and other cell types.
IL-18 plays a key role in regulating innate immune responses, affecting natural killer cells, monocytes and other cell types.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
